These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 18342640)
1. Octamers and nanoparticles as hemoglobin based blood substitutes. Baudin-Creuza V; Chauvierre C; Domingues E; Kiger L; Leclerc L; Vasseur C; Célier C; Marden MC Biochim Biophys Acta; 2008 Oct; 1784(10):1448-53. PubMed ID: 18342640 [TBL] [Abstract][Full Text] [Related]
2. Enhancing stability and expression of recombinant human hemoglobin in E. coli: Progress in the development of a recombinant HBOC source. Graves PE; Henderson DP; Horstman MJ; Solomon BJ; Olson JS Biochim Biophys Acta; 2008 Oct; 1784(10):1471-9. PubMed ID: 18489914 [TBL] [Abstract][Full Text] [Related]
7. [Current aspects in red blood cell substitutes]. Wang Y; Pan J; Yu Y Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):490-4. PubMed ID: 15250164 [TBL] [Abstract][Full Text] [Related]
9. Oxidized mono-, di-, tri-, and polysaccharides as potential hemoglobin cross-linking reagents for the synthesis of high oxygen affinity artificial blood substitutes. Eike JH; Palmer AF Biotechnol Prog; 2004; 20(3):953-62. PubMed ID: 15176904 [TBL] [Abstract][Full Text] [Related]
10. Artificial Oxygen Carriers: Exactly How Close Are We to an Ultimate Product? Simoni J Artif Organs; 2017 Apr; 41(4):316-318. PubMed ID: 28397406 [No Abstract] [Full Text] [Related]
12. [Hemoglobin-based oxygen carriers and trials to substitute red blood cells]. Smani Y; Labrude P; Vigneron C; Faivre B Transfus Clin Biol; 2007 Nov; 14(5):464-73. PubMed ID: 18295525 [TBL] [Abstract][Full Text] [Related]
13. High-level production of recombinant Arenicola marina globin chains in Escherichia coli: a new generation of blood substitute. Harnois T; Rousselot M; Rogniaux H; Zal F Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(3):106-16. PubMed ID: 19444743 [TBL] [Abstract][Full Text] [Related]
15. Processing of ferulic acid modified hemoglobin. Guo S; Wang P; Chen C; Meng Z; Qi D; Wang X Artif Cells Nanomed Biotechnol; 2016 Jun; 44(4):1075-9. PubMed ID: 26838267 [TBL] [Abstract][Full Text] [Related]
16. Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example. Chang TM Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):551-66. PubMed ID: 17090428 [TBL] [Abstract][Full Text] [Related]
17. Novel water-mediated hydrogen bonds as the structural basis for the low oxygen affinity of the blood substitute candidate rHb(alpha 96Val-->Trp). Puius YA; Zou M; Ho NT; Ho C; Almo SC Biochemistry; 1998 Jun; 37(26):9258-65. PubMed ID: 9649306 [TBL] [Abstract][Full Text] [Related]